Loading organizations...
Loading organizations...
Immunotherapies inducing immune response against cancer and tumor recurrenc
BeneVir Biopharm has raised $5.0M across 2 funding rounds.
BeneVir Biopharm has raised $5.0M in total across 2 funding rounds.
BeneVir Biopharm has raised $5.0M in total across 2 funding rounds.
BeneVir Biopharm's investors include Pansend.
BeneVir Biopharm has raised $5.0M across 2 funding rounds. Most recently, it raised $3.0M Series A Extension in February 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 16, 2016 | $3.0M Series A Extension | ||
| Nov 26, 2014 | $2.0M Other Equity | Pansend |